Gabapentin Market in US Size, Share, Up-coming Trends, Analysis, Manufactures, Regions, Leading Players, Outlook –Future and Forecast 2026

Latest research report on “Gabapentin Market in US” now available at high quality database of with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.

Get Free Sample Research Report @

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.

This report contains market size and forecasts of Gabapentin in US, including the following market information:
US Gabapentin Market Revenue, 2015-2020, 2021-2026, ($ millions)
US Gabapentin Market Consumption, 2015-2020, 2021-2026, (K MT)
US Gabapentin Production Capacity, 2015-2020, 2021-2026, (K MT)
Top Five Competitors in US Gabapentin Market 2019 (%)
The global Gabapentin market was valued at 1529.6 million in 2019 and is projected to reach US$ 1637.8 million by 2026, at a CAGR of 1.7% during the forecast period. While the Gabapentin market size in US was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gabapentin manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Gabapentin production and consumption in US

Total Market by Segment:
US Gabapentin Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K MT)
US Gabapentin Market Segment Percentages, By Type, 2019 (%)
– Capsule
– Tablet

US Gabapentin Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K MT)
US Gabapentin Market Segment Percentages, By Application, 2019 (%)
– Epilepsy
– Neuropathic Pain
– Restless Legs Syndrome
– Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Gabapentin Market Competitors Revenues in US, by Players 2015-2020 (Estimated), ($ millions)
Total Gabapentin Market Competitors Revenues Share in US, by Players 2019 (%)
Total US Gabapentin Market Competitors Sales, by Players 2015-2020 (Estimated), (K MT)
Total US Gabapentin Market Competitors Sales Market Share by Players 2019 ($ millions)

Further, the report presents profiles of competitors in the market, including the following:
– Pfizer
– Assertio Therapeutics
– Mylan
– Arbor Pharma
– Novartis
– Apotex
– Sun Pharmaceutical
– Aurobindo Pharma
– Intas
– Amneal
– Marksans Pharma
– Glenmark
– Alkem
– Jiangsu Enhua
– Jiangsu Hengrui

More information about Discount offers (20% or More)  @

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.

E-mail: [email protected]

Phone: +1 888 391 5441

Share This Post

Post Comment